Development of an antibody-like T-cell engager based on VH-VL heterodimer formation and its application in cancer therapy
Author:
Funder
Korea Ministry of Science and ICT
Korea Drug Development Fund
Publisher
Elsevier BV
Subject
Mechanics of Materials,Biomaterials,Biophysics,Ceramics and Composites,Bioengineering
Reference53 articles.
1. Hallmarks of cancer: the next generation;Hanahan;Cell,2011
2. Trends in the global immuno-oncology landscape;Tang;Nat. Rev. Drug Discov.,2018
3. Bispecific antibodies in cancer immunotherapy;Dahlen;Ther. Adv. Vacc. Immunother,2018
4. Bispecific T-cell engagers: towards understanding variables influencing the in vitro potency and tumor selectivity and their modulation to enhance their efficacy and safety;Ellerman;Methods,2019
5. Somatically generated mouse myeloma variants synthesizing IgA half-molecules;Zack;J. Exp. Med.,1981
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A bibliometric and knowledge-map analysis of bispecific antibodies in cancer immunotherapy from 2000 to 2023;Heliyon;2024-01
2. Revolutionizing cancer immunotherapy: unleashing the potential of bispecific antibodies for targeted treatment;Frontiers in Immunology;2023-12-01
3. Ex-vivo CS1-OKT3 dual specific bivalent antibody-armed effector T cells mediate cellular immunity against multiple myeloma;Scientific Reports;2023-11-27
4. IgG-like bispecific antibody platforms with built-in purification-facilitating elements;Protein Expression and Purification;2021-12
5. Humanized Mice as a Valuable Pre-Clinical Model for Cancer Immunotherapy Research;Frontiers in Oncology;2021-11-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3